Diagnostic Challenges and Surgical Management of Non-Healing Uterocutaneous Fistula: A Case Report
Journal of Fatima Jinnah Medical University · 2026-03-25 · 19 (3) · 155-58
DOI: 10.37018/hamx5232 ↗At a glance
Fallbericht in Journal of Fatima Jinnah Medical University, published online on 2026-03-25. Written by Sabahat Iftikhar and 3 co-authors. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Uterocutaneous fistula (UCF) is a rare condition, with only a few case reports mentioned in the literature. This report describes the management of a 30-year-old female who presented with bloodstained purulent discharge from a previous Pfannenstiel incision after cesarean section. The patient had developed a fistulous communication between the uterus and the anterior abdominal wall, and the discharge from the wound site increased during menstruation. This condition was refractory to medical management. Radiological investigations, including a fistulogram, showed a blind-ended tract extending from the skin into the subcutaneous tissue. A laparotomy was performed in which a uterocutaneous fistula was identified and managed surgically.
Cite
APA
Iftikhar, S., Shoukat, A., Ahmed, A., & Aslam, I. (2026). Diagnostic Challenges and Surgical Management of Non-Healing Uterocutaneous Fistula: A Case Report. Journal of Fatima Jinnah Medical University, 19(3), 155-58. https://doi.org/10.37018/hamx5232
Vancouver
Iftikhar S, Shoukat A, Ahmed A, Aslam I. Diagnostic Challenges and Surgical Management of Non-Healing Uterocutaneous Fistula: A Case Report. Journal of Fatima Jinnah Medical University. 2026;19(3):155-58. doi:10.37018/hamx5232
BibTeX
@article{Iftikhar2026,
author = {Iftikhar, Sabahat and Shoukat, Aleena and Ahmed, Arslan and Aslam, Imran},
title = {Diagnostic Challenges and Surgical Management of Non-Healing Uterocutaneous Fistula: A Case Report},
journal = {Journal of Fatima Jinnah Medical University},
year = {2026},
volume = {19},
number = {3},
pages = {155--58},
doi = {10.37018/hamx5232}
}
EUVIMED